This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Fuso Pharmaceutical Industries, Ltd.. Active years: 1998-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2000)
- Wakayama, JP (1998 - 2013)
Company Filing History:
Years Active: 1998-2013
Title: Innovations of Yuichiro Kishi
Introduction
Yuichiro Kishi is a notable inventor based in Wakayama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of collectin proteins. With a total of 4 patents to his name, Kishi's work is recognized for its potential applications in human health.
Latest Patents
Kishi's latest patents focus on isolated collectin (CL-L2s) genes. These genes include a base sequence set out in SEQ ID NO: 1, 3, 5, 7, 9, 12, 36, 38, or 40. They relate to a novel collectin expected to exhibit antibacterial and antiviral activities, particularly within the human body. Additionally, his patents cover isolated collectin proteins that include an amino acid sequence set out in SEQ ID NO: 2, 4, 6, 8, 10, 13, 37, 39, or 41, along with their derivatives and fragments.
Career Highlights
Yuichiro Kishi is currently associated with Fuso Pharmaceutical Industries, Ltd. His work at the company has been instrumental in advancing research in the field of pharmaceuticals and biotechnology. Kishi's innovative approach has led to breakthroughs that could enhance therapeutic options for various diseases.
Collaborations
Kishi has collaborated with notable colleagues, including Nobutaka Wakamiya and Hiroyuki Keshi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in their research endeavors.
Conclusion
Yuichiro Kishi's contributions to the field of biotechnology through his patents on collectin proteins highlight his innovative spirit and dedication to improving human health. His work continues to inspire advancements in medical research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile